Rachel E. Nally
Impact in
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
Papers in
-
- Neuroscience and Neuropharmacology Research 6
- Neurotransmitter Receptor Influence on Behavior 4
- Genetic Neurodegenerative Diseases 1
-
- Receptor Mechanisms and Signaling 3
- Co-authors
- Marina A. Lynch (3 shared papers)Yvonne M. Nolan (1 shared paper)Rebecca J. Griffin (1 shared paper)James D. Linden (1 shared paper)Rachael M. Clarke (2 shared papers)David J. Loane (1 shared paper)Aine Marie Kelly (1 shared paper)Aedín M. Minogue (1 shared paper)
- Journals
- Journal of Neurochemistry (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Neuropsychopharmacology (1 paper)European Neuropsychopharmacology (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- IrelandAustraliaUnited States
In The Last Decade
Rachel E. Nally
8 papers receiving 548 citations
Peers
Comparison fields: 5 of 65
- Neurology 275
- Biological Psychiatry 79
- Developmental Neuroscience 63
- Behavioral Neuroscience 38
- Cellular and Molecular Neuroscience 184
Countries citing papers authored by Rachel E. Nally
This map shows the geographic impact of Rachel E. Nally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Nally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Nally more than expected).
Fields of papers citing papers by Rachel E. Nally
This network shows the impact of papers produced by Rachel E. Nally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Nally. The network helps show where Rachel E. Nally may publish in the future.
Co-authors
The 25 scholars most cited alongside Rachel E. Nally, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 239 | |
| 2 | 2006 | 125 | |
| 3 | 2006 | 70 | |
| 4 | 2007 | 54 | |
| 5 | 2003 | 24 | |
| 6 | 2000 | 17 | |
| 7 | 2004 | 12 | |
| 8 | 2006 | 10 |
About Rachel E. Nally
Rachel E. Nally is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Neurology, Neurology and Immunology, having authored 8 papers that have together received 551 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Receptor Mechanisms and Signaling (3 papers), Neurological disorders and treatments (2 papers), Immune Response and Inflammation (2 papers), Cholesterol and Lipid Metabolism (1 paper) and Genetic Neurodegenerative Diseases (1 paper). The work is most often cited by research in Neurology (275 citations), Biological Psychiatry (79 citations), Developmental Neuroscience (63 citations), Behavioral Neuroscience (38 citations) and Cellular and Molecular Neuroscience (184 citations). Rachel E. Nally has collaborated with scholars based in Ireland, Australia and United States. Frequent co-authors include Marina A. Lynch, Yvonne M. Nolan, Rebecca J. Griffin, James D. Linden, Rachael M. Clarke, David J. Loane, Aine Marie Kelly, Aedín M. Minogue, Dana Kilroy and Aileen Lynch. Their work appears in journals such as Journal of Neurochemistry, Journal of Pharmacology and Experimental Therapeutics, Neuropsychopharmacology, European Neuropsychopharmacology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.